Disaggregated Revenues (Tables)

6 Months Ended

Jun. 30, 2022

Disaggregation of Revenue [Abstract]

Summary of disaggregation of revenues by nature

The following table summarizes the disaggregation of revenues by product or source (dollars in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
	(unaudited)				(unaudited)
Net product sales
Trokendi XR	$	71,602	$	78,777	$	134,434	$	150,596
Oxtellar XR	29,958		25,022		57,479		52,392
GOCOVRI	24,700		—		47,301		—
APOKYN	20,447		26,981		38,895		48,711
Qelbree	11,099		315		19,382		315
Other(1)	7,653		7,533		15,432		14,995
Total net product sales	$	165,459	$	138,628	$	312,923	$	267,009
Royalty revenues	4,592		2,701		9,634		5,252
Total revenues	$	170,051	$	141,329	$	322,557	$	272,261

______________________________

(1) Includes net product sales of MYOBLOC, XADAGO and Osmolex ER.